UCSF School of Pharmacy scientist Matthew P. Jacobson, PhD is the new recipient of a prestigious Sloan Research Fellowship awarded by the Alfred P. Sloan Foundation.
Left to right: Andrej Sali, PhD; Christopher Voigt, PhD; Ken Dill, PhD; and Anthony Hunt PhD
Some people see a future populated by billions of mechanical micromachines, robots no bigger than a speck of dust that are programmed to do our bidding. UCSF School of Pharmacy researcher Christopher Voigt, PhD sees a different future.
UCSF School of Pharmacy scientist Brian K. Shoichet, PhD was named by Thomson ISI in September 2003 for having written a Hot Paper in the field of chemistry.
By early spring 2004, five female scientists from the UCSF School of Pharmacy will have moved to Mission Bay, the University of California San Francisco's new 43-acre research campus.
Leslie Z. Benet, PhD, was named a Thomson ISI Highly Cited Researcher in December 2003. The designation means that Benet's research publications on pharmacokinetics and pharmacodynamics have been extensively cited by other scientists in their publications. Citation is an important way to measure...
R. William Soller, PhD is the new director of the Center for Consumer Self Care, UCSF School of Pharmacy. The Center supports research on consumer behavior and health policy issues related to prescription and non-prescription medicines and dietary supplements.
The UCSF School of Pharmacy will establish its first distinguished professorship following a gift from one of its most illustrious alums. Harry Wm. Hind—inventor of both the Lidoderm® patch and the wetting solution that helped bring contact lenses into widespread use—and his wife, Diana V.
Irwin (Tack) D. Kuntz, PhD, professor, Department of Pharmaceutical Chemistry, UCSF School of Pharmacy has been named the 2003 Volwiler Research Achievement Award recipient by the American Association of Colleges of Pharmacy (AACP).
Tom James, PhD, chair of the department of pharmaceutical chemistry, UCSF School of Pharmacy, is looking for new drug models that act directly on RNA rather than protein, where most drug work is now being done. Why?
